Latest News

Full year earnings put Migdal’s recent share performance in focus Migdal Insurance and Financial Holdings (TASE:MGDL) recently reported full year 2025 earnings, with net income of ₪1,832 million and basic earnings per share from continuing operations of ₪1.73. Those figures compare with net income of ₪1,419 million and basic earnings per share of ₪1.35 a year earlier, giving investors fresh numbers to weigh against the stock’s recent price moves. See our latest analysis for Migdal Insurance...

Why Whirlpool Might Be Back On Your Radar Whirlpool (WHR) has recently drawn attention after a period of mixed share performance, with the stock showing gains over the past week but weaker returns over the past month and past 3 months. See our latest analysis for Whirlpool. While the 1 day share price return of 2.19% and 7 day share price return of 9.04% suggest a short term rebound, the 30 day and year to date share price returns and multi year total shareholder returns indicate that...

In late March 2026, Duke Energy received positive dam safety inspection correspondence from the Federal Energy Regulatory Commission and secured South Carolina approval to build a highly efficient, lower‑water‑use natural gas plant in Anderson County. Together with the completed sale of its Tennessee gas distribution business, these developments highlight Duke Energy’s focus on regulated infrastructure, operational safety and long-term regional energy needs. With these approvals and asset...

MediWound Ltd. recently announced that Vericel Corporation, its exclusive North American distributor for NexoBrid, secured a ten-year BARDA contract worth up to US$197 million to supply NexoBrid, build and manage a Vendor Managed Inventory system, support U.S.-based manufacturing, and fund next-generation formulation and indication development. A key feature of this agreement is dedicated funding for NexoBrid purchases into the U.S. Strategic National Stockpile and early work on a potential...

Healthcare Services Group (HCSG) has been drawing attention after a strong 1 year total return of 85.35%, in contrast with recent share price softness over the past month and past 3 months. See our latest analysis for Healthcare Services Group. Recent trading has cooled after that strong 1 year total shareholder return of 85.35%. The 30 day share price return of an 11.14% decline points to fading near term momentum, even as the longer term total shareholder return profile remains positive...

TimesSquare Capital Management recently added Axogen, Inc. to its U.S. Small Cap Growth Strategy, following the company’s report of US$59.9 million in fourth-quarter 2025 revenue and 21.3% year-over-year growth from its peripheral nerve repair portfolio. A key element of the story is Axogen’s Avance Nerve Graft, currently the only FDA-approved implantable biological nerve allograft, which underscores its differentiated position in peripheral nerve regeneration. We’ll now examine how Axogen’s...

Recent performance snapshot for Futu Holdings (NasdaqGM:FUTU) Futu Holdings (NasdaqGM:FUTU) has seen mixed share performance recently, with a modest move over the past week, a small decline over the month, and a sharper negative return across the past 3 months. Against that backdrop, the stock’s 1 year and 3 year total returns, current valuation metrics, and the company’s reported revenue and net income levels give investors several concrete reference points when assessing what the recent...

Roche Holding (SWX:ROP) has attracted fresh attention after announcing the cobas MPX-E assay, a CE-marked in vitro test that screens for HIV and multiple hepatitis viruses in a single high-throughput run. See our latest analysis for Roche Holding. Roche’s recent diagnostics launches and R&D investment news arrive while the share price sits at CHF318.0, with a 30 day share price return of a 6.8% decline but a 1 year total shareholder return of 33.17% that points to stronger long term...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

f-code Inc.'s ( TSE:9211 ) solid earnings announcement recently didn't do much to the stock price. We did some analysis...

Insiders who purchased US$3.09m worth of Genmin Limited ( ASX:GEN ) shares over the past year recouped some of their...

In late March 2026, Stagwell expanded The Harris Poll’s HarrisQuest brand and reputation tracking platform into Europe and introduced Lou, an AI analyst embedded in HarrisQuest to deliver rapid, self-serve insight generation for marketers and executives across 24 countries. Together with the appointment of Michael Twedell as Stagwell’s first Senior Vice President for Enterprise AI Solutions, these moves highlight a push to embed AI deeper into the company’s SaaS marketing stack and...

Eastern Bank recently promoted Jennifer Wambold, formerly Senior Vice President of Total Rewards and Benefits, to Executive Vice President and Chief People Officer, adding her to the bank’s Management Committee after she joined in 2025 to lead compensation, benefits and recognition strategies. Her appointment brings three decades of human resources experience in leading organizations through change to Eastern Bank’s top leadership group, reinforcing the emphasis on aligning culture with...

nVent Electric (NVT) is back on investors’ radars after recent share price moves. The stock last closed at US$117.96, putting fresh attention on what the current valuation reflects. See our latest analysis for nVent Electric. The recent pullback, including a 2.7% one day share price decline, sits against a 30 day share price return of 11.3% and a very large 1 year total shareholder return of 157.7%. This suggests momentum has been strong over both short and longer periods. If nVent’s move has...

Alignment Healthcare (ALHC) just reported quarterly results with 44.4% year on year revenue growth and beats on both revenue and earnings. However, cautious next quarter revenue guidance led to a sharp 8.5% stock drop. See our latest analysis for Alignment Healthcare. At a share price of US$18.76, Alignment Healthcare has seen a 5.10% 1 day share price gain and 11.34% 7 day share price return, but an 11.92% 90 day share price decline. The 3 year total shareholder return is very large,...

Amkor Technology, Inc. recently drew attention as a leading U.S.-headquartered provider of outsourced semiconductor packaging and test services, with investors focusing on its expanding role in AI-related packaging and on the upcoming release of its first-quarter 2026 results, which were scheduled and later held on April 27, 2026. An interesting angle is Amkor’s position as one of only two U.S. companies capable of delivering large-scale advanced packaging solutions, a capability that has...

RTX stock snapshot and recent performance context RTX (RTX) has been on investors’ radar after a period of mixed share performance, with a roughly 5% gain over the past week, a 6% decline over the past month, and a 3% rise over the past 3 months. At a last close of US$196.21 and a market value of about US$264.1b, the aerospace and defense group shows year to date and 1 year total returns of about 4.8% and 70.1%. Over 3 years and 5 years, total returns are roughly 110.3% and 178.8%,...

Why Palomar Is On Investors’ Radar Today Palomar Holdings (PLMR) is drawing fresh attention as investors compare its return on equity, net margin, and projected earnings growth with peers like Axis Capital, alongside its push into digital distribution and automated underwriting technology. See our latest analysis for Palomar Holdings. Palomar’s recent share price performance has softened, with a 30 day share price return showing a decline of 5.67% and a year to date share price return showing...

Disc Medicine, Inc. recently reported that the last participant has been randomized and dosed in its expanded pivotal Phase 3 APOLLO trial of bitopertin in erythropoietic and X-linked protoporphyria, while the program also faces an FDA Complete Response Letter citing insufficient efficacy in earlier trials. This combination of advancing a potentially first disease-modifying therapy in a rare blood disorder and addressing regulatory efficacy concerns creates a complex risk-reward profile for...

Why Texas Roadhouse Is Back on Income Investors’ Radar Recent commentary around Texas Roadhouse (TXRH) has focused on its raised quarterly dividend, steady positive comparable restaurant sales through 2025 and early 2026, and supportive guest traffic trends. In a backdrop where some peers face negative comparable sales and pay no dividends, this mix of income and operational momentum is drawing fresh attention from retirement focused investors looking for restaurant exposure. See our latest...

Dividend track record comes into focus for income investors Recent attention on InvenTrust Properties (IVT) centers on its pattern of dividend growth, including a new 5.2% increase in the current annualized payout, as investors reassess the reliability of its income stream. See our latest analysis for InvenTrust Properties. At a share price of $30.73, InvenTrust’s recent 9.05% 3 month share price return and 19.32% 1 year total shareholder return suggest momentum has been building alongside...

Oracle appointed Hilary Maxson as Chief Financial Officer, replacing its previous finance leadership during a period of major change. The move comes as Oracle ramps up AI infrastructure efforts, carries out large scale layoffs, and faces scrutiny over workforce and hiring practices. Maxson will oversee capital allocation, spending, and balance sheet decisions at a time when investors are focused on AI investment plans and cost structure. For investors watching NYSE:ORCL, this leadership...

Universal Technical Institute recently delivered a strong quarter with revenue rising 9.6% year on year and earnings ahead of analysts’ estimates, as management emphasized solid execution of its North Star strategy. Truist Securities responded by reaffirming its constructive stance on the company, underscoring confidence in accelerating student enrollments and the potential impact of new business-to-business partnerships. With Universal Technical Institute outperforming revenue and profit...

Carvana (CVNA) is back in focus after reporting record profit levels, with retail auto sales near 600,000 vehicles and fourth quarter revenue up 58% year over year, sharpening attention on valuation and governance. See our latest analysis for Carvana. Carvana’s latest results land after a volatile stretch, with a 7.95% 7 day share price return but a 21.57% decline year to date. The 1 year total shareholder return sits at 87%, which points to strong long term momentum despite recent...